Skip to content

Teladoc Health and Livongo issue updates on merger

September 16, 2020

Teladoc Health (NYSE:TDOC) and Livongo (NASDAQ:LVGO) have filed the joint proxy statement and prospectus with the SEC in connection with the proposed merger of the two companies.

Special meetings will be held on October 29, wherein stockholders will be entitled to vote.

The Teladoc and Livongo Boards of Directors each unanimously recommends their respective stockholders vote “For” the proposed merger set forth in the proxy statement.

As described in the prospectus, each share of Livongo will be exchanged for 0.5920 Teledoc shares plus cash consideration of $4.24.

Additionally, prior to the closing of the merger, LVGO will pay a cash dividend of $7.09/share.

The transaction is on track to close by the end of Q4.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: